The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity and patient-provider communication about cancer-related cost among prostate cancer patients and survivors.
 
Elissa C. Kranzler
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Janssen/Pharmacyclics; Jazz Pharmaceuticals; Takeda
 
Melissa F. Miller
No Relationships to Disclose
 
Erica E. Fortune
Research Funding - Boston Scientific Foundation; Genentech; Gilead Sciences
 
Daniel M. Geynisman
Employment - 2nd.MD
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Merck (Inst)
 
Linda S. Bohannon
Consulting or Advisory Role - Alkermes (Inst); Amgen (Inst); Genentech (Inst); Novartis (Inst); Novartis (Inst); Oncopeptides (Inst)
Research Funding - See CSC annual report (Inst)
Patents, Royalties, Other Intellectual Property - CSC owns Patient Planning Services (PPS). PPS licenses CSC's distress screening tool and hospital partner models to healthcare institutions. (Inst)
 
Heather Badt
No Relationships to Disclose
 
Alexandra Katherine Zaleta
Research Funding - Athenex (Inst); Gilead Sciences (Inst); Pfizer (Inst)